- Home
- NECB vs HUMA Comparison
NECB vs HUMA Comparison
Compare NECB & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NECB | HUMA |
|---|---|---|
| Founded | 1934 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 282.4M | 236.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | NECB | HUMA |
|---|---|---|
| Price | $21.93 | $1.23 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $10.13 |
| AVG Volume (30 Days) | 45.1K | ★ 4.8M |
| Earning Date | 10-23-2025 | 11-12-2025 |
| Dividend Yield | ★ 4.56% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.21 | N/A |
| Revenue | ★ $102,569,000.00 | $1,571,000.00 |
| Revenue This Year | $1.90 | N/A |
| Revenue Next Year | $6.93 | $731.05 |
| P/E Ratio | $6.82 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $19.27 | $1.09 |
| 52 Week High | $29.74 | $6.77 |
Technical Indicators
Market Signals| Indicator | NECB | HUMA |
|---|---|---|
| Relative Strength Index (RSI) | 63.88 | 41.25 |
| Support Level | $21.00 | $1.23 |
| Resistance Level | $22.19 | $1.33 |
| Average True Range (ATR) | 0.53 | 0.09 |
| MACD | 0.20 | 0.02 |
| Stochastic Oscillator | 86.43 | 48.28 |
Price Performance
Historical ComparisonAbout NECB NorthEast Community Bancorp Inc.
NorthEast Community Bancorp Inc operates as a community-oriented financial institution. It is principally engaged in the business of attracting deposits and investing those funds into mortgage and commercial loans. It conducts activities throughout the Northeastern United States including New York, Massachusetts, New Jersey, and Connecticut. The company offers a comprehensive line of banking products and services, including mobile banking as well as commercial real estate loans, commercial construction financing, lines of credit, and term loans. It also offers investment advisory and financial planning services.
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.